Cardinal Health (CAH) Long-Term Investments (2009 - 2023)
Cardinal Health's (CAH) quarterly Long-Term Investments came in at $147.0 million in Q3 2023, down 62.69% quarter-over-quarter from $394.0 million in Q3 2018.
Cardinal Health (CAH) Long-Term Investments (2009 - 2023) Analysis & Trends
Cardinal Health has disclosed Long-Term Investments across 4 years of filings, most recently posting $147.0 million for Q3 2023.
- Long-Term Investments for Q3 2023 came in at $147.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $147.0 million (changed N/A YoY), and the FY2018 annual result was $50.0 million, changed N/A from the prior year.
- Long-Term Investments came in at $147.0 million for Q3 2023 at Cardinal Health, down from $394.0 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $147.0 million in Q3 2023 to a low of $147.0 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | - |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | - |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 587.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | - |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 147.00 Mn |
| Sep 30, 2018 | 394.00 Mn |
| Jun 30, 2018 | 50.00 Mn |
| Jun 30, 2010 | 691.50 Mn |
| Mar 31, 2010 | 805.20 Mn |
| Dec 31, 2009 | 897.40 Mn |
| Sep 30, 2009 | 902.40 Mn |